IBM Faces a High-Stakes Earnings Call as Legal Probes Mount and the AI Boom Undermines Its Core Business
Published on 07/22/2026 at 17:33 | Redaktion boerse-global.de
IBM enters Wednesday’s full-year earnings call under a cloud of legal scrutiny and operational headwinds, with the stock trading near its 52-week low and five law firms probing potential securities violations. The company’s shares closed at €184.68 on Tuesday, a decline of 1.02%, and sit just 3.45% above the 52-week trough of €178.52 hit on July 16. Since reaching a June high of €292.85, the stock has shed nearly 37% of its value.
The turmoil traces back to July 14, when IBM released preliminary second-quarter results that revealed a stark disconnect between its legacy strengths and the market’s AI-driven priorities. The company acknowledged that a “decline in Z-performance and the associated software stack” weighed on the quarter, particularly in transaction processing, and admitted it “did not react quickly enough,” causing “numerous large orders not to be completed within the expected timeframe.” That admission triggered the largest single-day share price drop in the company’s history.
The fallout has been swift. At least five law firms—Bleichmar Fonti & Auld, Glancy Prongay & Murray, Hagens Berman, Schall Law, and Bronstein, Gewirtz & Grossman—have launched investigations into whether IBM misled investors about deal momentum and the outlook for its Z business. Hagens Berman is zeroing in on a particularly sensitive timeline: on April 22, IBM reported a strong start to the year, with infrastructure revenue surging 15%, hybrid infrastructure up 28%, and IBM Z jumping 51%. The firm wants to determine whether the company already knew those large deals were faltering when it issued that upbeat report.
The structural problem at the heart of IBM’s predicament is a paradox of the AI boom. While the technology sector celebrates surging demand for AI servers and hardware, that very trend is cannibalizing IBM’s traditional software and consulting revenue. Customers are redirecting capital toward AI infrastructure from competitors, leaving less budget for IBM’s hybrid cloud and mainframe offerings. The numbers tell the story: software revenue rose 5% in the quarter, with Red Hat up 11%, but infrastructure—once a reliable pillar—contracted 7%, a sharp reversal from the 15% growth recorded in the first quarter.
Should investors sell immediately? Or is it worth buying IBM?
Analyst sentiment reflects the uncertainty. Oppenheimer’s Param Singh downgraded the stock to “Perform” and scrapped his $350 price target, noting that IBM missed both its own estimates and consensus in every segment. HSBC is the most bearish among major banks, having cut its rating before the full market reaction; it argues that IBM trades at 22 times expected 2027 adjusted earnings, well above the sector median of 16.9 times, while its adjusted earnings per share are forecast to grow just 10.7% annually between 2026 and 2028, compared with 19.2% for the sector. HSBC’s price target implies a further 33.6% downside.
Yet not all analysts are so pessimistic. Among the 22 analysts covering IBM, the consensus is a “Moderate Buy” with an average price target of roughly $293.95—well above current levels. Baird initiated coverage with a “Neutral” rating, citing doubts about software growth and the duration of the current mainframe cycle. The gap between long-term optimism and near-term caution underscores how much hinges on tonight’s call.
The cash flow picture adds another layer of urgency. IBM has set a 2026 free cash flow target of approximately $15.7 billion, but to hit that, it needs to generate about $10.9 billion in the second half of this year—more than double the $4.8 billion produced in the first half. That would require a 10% improvement over the same period last year, a steep climb given the current headwinds.
Technically, the stock is flashing oversold signals. The 14-day relative strength index stands at 31.1, approaching the threshold that typically indicates a beaten-down asset. The annualized 30-day volatility is elevated at 83.8%, an unusually high level for a $175 billion market-cap tech stalwart.
IBM at a turning point? This analysis reveals what investors need to know now.
Wednesday’s conference call, scheduled for 5 p.m. Eastern time, follows the preliminary July 14 release and is expected to provide clarity on delayed deals, segment-level guidance, and free cash flow outlook—particularly critical given the dividend commitments. Every management comment will be parsed not just by investors but by the legal teams building their cases. A credible roadmap for closing the delayed transactions could stabilize sentiment; any admission that supports the claim that IBM misrepresented deal dynamics and Z prospects would feed directly into the shareholder lawsuits.
CEO Arvind Krishna has described the company’s performance as a “stumble,” but the stakes go beyond a single quarter. With the stock down nearly 29% year-to-date, Krishna must deliver more than numbers—he needs to articulate how IBM will navigate an AI revolution that is simultaneously undermining its core business and reshaping the competitive landscape.
Ad
IBM Stock: New Analysis - 22 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
